Sandra N Slagter
Overview
Explore the profile of Sandra N Slagter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
710
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wouters H, Slagter S, Muller Kobold A, van der Klauw M, Wolffenbuttel B
PLoS One
. 2020 Nov;
15(11):e0242795.
PMID: 33237973
Background: Thyroid hormone plays a pivotal role in human metabolism. In epidemiologic studies, adequate registration of thyroid disorders is warranted. We examined the prevalence of thyroid disorders, reported thyroid medication...
2.
van Waateringe R, Fokkens B, Slagter S, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, et al.
Diabetologia
. 2018 Nov;
62(2):269-280.
PMID: 30460578
Aims/hypothesis: Earlier studies have shown that skin autofluorescence measured with an AGE reader estimates the accumulation of AGEs in the skin, which increases with ageing and is associated with the...
3.
Slagter S, Corpeleijn E, van der Klauw M, Sijtsma A, Swart-Busscher L, Perenboom C, et al.
Nutr J
. 2018 Feb;
17(1):18.
PMID: 29433580
Background: Diversity in the reported prevalence of metabolically healthy obesity (MHO), suggests that modifiable factors may be at play. We evaluated differences in dietary patterns and physical activity between MHO...
4.
Wolffenbuttel B, Wouters H, Slagter S, van Waateringe R, Muller Kobold A, van Vliet-Ostaptchouk J, et al.
BMC Endocr Disord
. 2017 Oct;
17(1):65.
PMID: 29037214
Background: The metabolic syndrome (MetS) is a combination of unfavourable health factors which includes abdominal obesity, dyslipidaemia, elevated blood pressure and impaired fasting glucose. Earlier studies have reported a relationship...
5.
Savas M, Muka T, Wester V, van den Akker E, Visser J, Braunstahl G, et al.
J Clin Endocrinol Metab
. 2017 Oct;
102(10):3765-3774.
PMID: 28973553
Context: Use of systemic corticosteroids (CSs) may induce adverse cardiometabolic alterations, potentially leading to obesity and metabolic syndrome (MetS). Although evidence is accumulating that local CSs have considerable systemic effects,...
6.
van Waateringe R, Mook-Kanamori M, Slagter S, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, et al.
PLoS One
. 2017 Jun;
12(6):e0179330.
PMID: 28632785
Background: Skin autofluorescence, a biomarker for advanced glycation end products (AGEs) accumulation, has been shown to predict diabetes-related cardiovascular complications and is associated with several environmental and lifestyle factors. In...
7.
van Waateringe R, Slagter S, van Beek A, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, et al.
Diabetol Metab Syndr
. 2017 Jun;
9:42.
PMID: 28572855
Background: The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced...
8.
Slagter S, van Waateringe R, van Beek A, van der Klauw M, Wolffenbuttel B, van Vliet-Ostaptchouk J
Endocr Connect
. 2017 Apr;
6(4):278-288.
PMID: 28420718
Introduction: To evaluate the prevalence of metabolic syndrome (MetS) and its individual components within sex-, body mass index (BMI)- and age combined clusters. In addition, we used the age-adjusted blood...
9.
Wouters H, van Loon H, van der Klauw M, Elderson M, Slagter S, Kobold A, et al.
Thyroid
. 2016 Nov;
27(2):147-155.
PMID: 27786042
Introduction: The presence of the Thr92Ala polymorphism of deiodinase-2 (D2) has been thought to have several effects. It may influence its enzymatic function, is associated with increased expression of genes...
10.
van Waateringe R, Slagter S, van der Klauw M, van Vliet-Ostaptchouk J, Graaff R, Paterson A, et al.
Eur J Clin Invest
. 2016 Mar;
46(5):481-90.
PMID: 27002914
Background: Skin autofluorescence (SAF) is a noninvasive marker of advanced glycation end products (AGEs). In diabetes, higher SAF levels have been positively associated with long-term complications, cardiovascular morbidity and mortality....